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ABSTRACT 
 
Introduction: Breast cancer is the most common cancer affecting women globally. The essential 
fatty acid α-Linolenic acid (ALA) and its oxidation products inhibit cancer cell proliferation. The 
effect of natural antioxidants on ALA anticancer effects has not been well characterized.   
Aims: To assess the effect of curcumin and neem leaf powder extract, on ALA cytotoxicity activity 
towards MCF-7 breast cancers.  
Study Design: In-vitro testing. 
Methodology: Antioxidant activity of neem extract and curcumin were evaluated using, four 
assays: Total phenolic content, Ferric reducing antioxidant power (FRAP), 2, 2-diphenyl-1-
picrylhydrazyl (DPPH) assay or 2, 2′-azino-bis-3-ethylbenzthiazoline-6-sulphonic acid (ABTS) 
assay. Cytotoxicity activity was assessed using MCF7 cells grown in DMEM (+10% FBS) and 
evaluated using Sulforhodamine B colorimetric assay for cell cytotoxicity.  
Original Research Article 
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Results: Curcumin and neem leaf extract had significant antioxidant power, and values varied 
between the four assays. Treatments of MCF7 cells with ALA, (0-500 µM) curcumin (0-50 µM), and 
neem leaf extract (0-88 µM) individually produced a concentration-dependent decrease in MCF-7 
cell viability. Combination treatments using ALA with curcumin and ALA with neem were 
significantly less effective compared to individual treatments.  
Conclusion: Combinations studies indicate that the natural antioxidants curcumin and neem 
reduce the inhibitory effect of α-Linolenic acid towards MCF-7 breast cancer cells. 
 
 
Keywords: Antioxidant; total phenols; curcumin, neem (Azadirachta indica), linolenic acid; MCF-7 cell; 
anticancer. 
 
1. INTRODUCTION  
 
Cancer is a debilitation disease that afflicts a 
noticeable proportion of the world population in 
all generations. Breast cancer is the most 
common cancer among women globally with 
1.67 million new cases diagnosed in 2012 and 
accounting for 25% of all cancers [1]. Diet is a 
moderating factor for cancer risk and high 
intakes of marine and fish derived n-3 fatty acids 
were associated with reduced risk of cancer 
though the relations are controversial [2]. Past 
investigations showed that Essential Fatty Acids 
(EFAs) inhibit the proliferation breast cancer cells 
[3,4] and that lipid peroxidation products may be 
implicated; reviewed in [5-8]. Alpha-Linolenic 
acid (ALA) is an unsaturated fatty acid that is 
essential for humans since it is not produced 
within the human body. Dietary ALA is converted 
to Eicosapentaenoic Acid (EPA), and 
Docosahexaenoic Acid (DHA) but the conversion 
rate may be variable depending on a range of 
factors including age [9]. Breast cancer cells 
have an increased requirement for n-3 fatty acids 
owing to a low D6 desaturase activity for 
converting ALA to EPA and DHA [3,8]. 
 
Recent attention has focused on antioxidants, 
herbals and traditional medicines from natural 
sources [10]. Curcumin from the spice turmeric 
expresses anticancer activity via multiple 
pathways linked with inflammation signaling, cell 
proliferation, invasion, cell death and gene 
expression (reviewed in [11-14]) and is currently 
undergoing Phase I-II clinical trials [13]. Neem 
(Azadirachta indica) leaf has been a traditional 
herbal agent for therapeutic and agricultural uses 
[15-17]. Recent investigations noted significant 
in-vitro antioxidant and free radical quenching 
activity for curcumin [18-22] and neem [23-27]. 
However, no single study comparing the 
antioxidant capacity of curcumin and neem using 
a range of antioxidant assays have been 
published. 
The anticancer effects of n-3 polyunsaturated 
fatty acids (PUFA) are partly attributed to lipid 
hydroperoxides formed by enzymatic or non-
enzymatic oxidation, which processes are 
inhibited by the antioxidant vitamin E [28-30]. 
Currently, the majority of investigations of n-3 
fatty acids and MCF-7 breast cancer cells 
focused on DHA and EPA rather than ALA. In-
vitro tests using MCF-7 cells treated with 
curcumin [31-35] or neem leaf extract [36] 
showed anti-proliferative activity but the                      
modes of action are not understood. No                     
reported studies have considered the effect                       
of curcumin or neem leaf extract on                             
ALA anticancer activity. Herbal agents may 
exhibit a pro-oxidant or antioxidant effect 
depending on their concentrations and so the 
consequences of combining such compounds 
with ALA are uncertain. The hypothesis tested in 
this study was that, combination treatments with 
ALA and natural antioxidants will affect 
cytotoxicity activity towards MCF-7 breast         
cancer cells. To address current research                      
gaps, the aims of this study were; (a) to                 
examine antioxidant activity of curcumin and 
neem leaf powder using a variety of in-vitro 
assays, and (b) to examine the effect of ALA, 
curcumin and neem leaf extracts on breast 
cancer cell proliferation individually and in 
combination. 
 
2. MATERIALS AND METHODS  
 
2.1 Materials  
 
Curcumin powder (>98% pure) was purchased 
from Sigma-Aldrich. All additional reagents                    
were analytical grade, purchased from Sigma-
Aldrich and used as received. Neem 
(Azadirachta indica) leaf powder was originally 
produced in India, and supplied by TOP-OP 
(Foods) Ltd, MIDDX, UK (www.top-op.com) and 
phosphate buffered saline (PBS) was obtained 
from Oxoid Ltd.  
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2.2 Antioxidant Assays 
 
2.2.1 Instrumentation 
 
Colorimetric measurements were recorded using 
a UV/ Visible spectrophotometer (Ultrospec 
2000, Pharmacia Biotech, Uppsala Sweden) in 
conjunction with 1-cm polystyrene cuvettes 
(Sarsted Ltd., Leicester, UK). All microplate 
assays involved a 96-microplate reader 
(VERSAmax; Molecular devices, Sunnydale, 
California, USA) used with flat-bottomed 96-well 
microplates (NUNC, Sigma Aldrich, UK). 
 
2.2.2 Sample extractions and reference 
antioxidants preparation 
 
Curcumin powder (51 mg) was dissolved in 50 ml 
of methanol and the mixture was centrifuged. 
Neem leaf extract was prepared by stirring 1 g of 
power with 9 g of distilled water then transferring 
1 ml of the mixture to another 9 g of distilled 
water. The mixture was centrifuged and the 
solids-content for the supernatant was 
determined by oven drying. Curcumin or neem 
leaf extracts were diluted using distilled water or 
PBS and analyzed for total antioxidant capacity 
(TAC) and total phenolic content (TPC) as 
described below.  
 
2.2.3 Ferric Reducing Antioxidant Potential 
(FRAP) assay 
 
The ferrozine ferric reducing antioxidant power 
(FRAP) assay is based on the reducing power of 
a sample. It measures the reduction of Fe3+ 
(ferric iron) to Fe2+ (ferrous iron) and detection 
using ferrozine as dye. A ferrozine FRAP assay 
was used in this study as described by Butts and 
Mulvihill [37] with slight modifications. The assay 
was performed at pH 7.0 using Tris buffer and 
using ferric ammonium citrate in place of ferric 
chloride. Curcumin extracts (diluted 1-16 fold,                 
DF = 1-16) and neem leaf extracts (DF= 10-320) 
were prepared as previously described. Diluted 
samples (20 µl) were added to 96 micro-well 
plates, 280 µl of ferrozine working solution was 
added, and samples were incubated for 30 min 
at 37°C. Absorbance measurements were 
recorded at 562 nm using a microplate reader. 
  
2.2.4 The 2.2-diphenyl-1-picryhydrazyl free 
radical scavenging assay 
 
The 2.2-diphenyl-1-picryhydrazyl (DPPH)   assay 
was modified from [38,39]. Briefly, a                      
DPPH working solution was prepared by                 
diluting 10 ml of DPPH stock (24 mg in                    
100 ml methanol) with 45 ml methanol to                  
reach the initial absorbance of 0.7±0.03 at                  
515 nm using a 1 cm spectrophotometer. 
Curcumin extracts (DF =1-16) and neem leaf 
extracts (DF = 40-1000) were prepared as 
previously mentioned. Diluted samples (20 µl) 
were added to 96 micro-well plate and 280 µl of 
DPPH solution was added into the plate. The 
mixtures were incubated in darkness for 30 min 
at 37°C and then absorbance measurements 
were recorded at 515 nm using a microplate 
reader. 
 
2.2.5 The 2,2-azinobis (3-ethyl-
benzothrazoline-6-sulfonic acid radical 
cation de-colorization assay 
 
The 2,2-azinobis (3-ethyl-benzothrazoline-6-
sulfonic acid (ABTS) assay was modified                      
from [40]. Briefly, 27.4 mg of ABTS and                 
2 mg of sodium persulfate were dissolved       
with 90 ml and 10 ml of phosphate-buffer                   
saline (PBS), respectively. The ABTS                 
working solution was prepared in 100 ml 
volumetric flask by mixing ABTS and sodium 
persulfate stock solutions and storing in the dark 
overnight at room temperature. Before use, 
ABTS solutions were diluted with PBS until to an 
initial absorbance value of 0.85 at 734 nm using 
a 1 cm spectrophotometer. For sample analysis 
(20 µl) of curcumin (DF=1-75) or neem leaf 
extracts (DF=10-1000) were added to 96 micro-
well plate and 280 µl of ABTS solution was 
added. The mixtures were incubated for 30 min 
at 37°C and then absorbance measurements 
were recorded at 734 nm using a microplate 
reader. 
 
2.2.6 Total phenolic content  
 
Total phenolic contents (TPC) were determined 
using the Folin-Denis method modified from                 
[41]. The diluted samples (50 µl) of curcumin                
(DF = 1-16)  or neem leaf extracts (DF= 10-160) 
were added to micro-centrifuge tube, followed                      
by 100 µl of Folin-Denis regent, 800 µl of                  
sodium carbonate reagent and 50 µl of        
methanol. The samples were vortexed                      
gently, incubated at 37°C for 20 min                               
and centrifuged at 11,000 rpm for 5 min.                          
The clear supernatant (200 ul) were transferred             
to 96 micro-well plates and absorbance                       
was measured at 760 nm using a microplate 
reader. 
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2.3 Cytoxcity Assay 
 
2.3.1 Cell culture 
 
MCF-7 cells (American Type Cell Culture) were 
cultured in Dulbecco’s modified eagle’s medium 
(DMEM; GIBCO) with 10% fetal bovine serum 
(FBS), 1% w/v penicillin streptomycin (Pen Strep) 
and 1% minimum essential medium non-
essential amino acids (MEM NEAA). Culture 
flasks and 96-microwell plates were incubated in 
a humidified incubator at 37°C in O2 95% 5% 
CO2. (LEEC research incubator, LEEC, UK). 
Cells were trypsinised, counted using a 
NucleoCounter (NC-3000, ChemoMetec, 
Denmark) and seeded (10,000 cells/well) in 96-
microwell plates with 50 µl of culture medium 
overnight to allow cell attachment. Cell growth 
was monitored using the Sulforhodamine B 
assay for cell cytotoxicity (see below). 
 
2.3.2 In-vitro cytotoxicity tests 
 
Curcumin and ALA (≥99% pure) were diluted in 
methanol (HPLC grade, ≥99.9%) to make 10mM 
stock solutions. Neem leaf extracts were 
prepared as above (section 2.2.2) and their 
concentrations were determined by the TPC 
method in terms of gallic acid equivalence. Stock 
solutions were then diluted with culture medium 
10-fold for curcumin and neem leaf extracts and 
5-fold for ALA, and filter sterilized with 0.20-µm 
cellulose acetate filters. The sterile solution of 
curcumin, neem leaf extract or ALA was further 
diluted with culture medium. Cells were treated 
with various concentrations of curcumin (0-100 
µM), neem leaf extracts (0-176 µM) or ALA (0-
1000 µM; 50 µl) and incubated at 37°C for 72 hr. 
The final concentration of methanol for treated 
cells was less than 0.1% which is non-toxic to 
MCF-7 cells. For the control study, cells were 
treated with culture medium only. For 
combination studies, cells were treated with 
50:50 mixtures prepared using 4x the desired 
“within-well” concentrations of ALA with neem 
extract, or ALA with curcumin. All other 
techniques were as described previously.  
 
2.3.3 Sulforhodamine B (SRB) Assay for cell 
cytotoxicity 
 
The sulforhodamine B (SRB) assay for 
cytotoxicity is a colorimetric assay to determine 
cell numbers based on the detection of cell 
proteins [42]. Cells were treated as previously 
mentioned. The cells were fixed with 100 µl of 
cold 10% (w/v) Trichloroacetic Acid (TCA) and 
incubated at 5°C for an hour. After four washings 
with tap water and air-drying, the cells were 
stained for 30 min at room temperature with 
0.06% SRB dye solution dissolved in 1% acetic 
acid (100 µl/well) and subsequently rinsed four 
times with 1% (v/v) acetic acid to remove 
unbound stain. After drying, Trizma–base (200 
µl/well, 10 mM) was added to the plate to 
solubilize SRB dye, and the plates were shaken 
using an Orbital Shaker for 5 min (Speed: 180 
revs/min). Absorbances were measured at                 
564 nm using a microplate reader and the data 
was transferred to MS excel and SPSS for 
further analyses. Cell viability was calculated as 
a percentage of absorbance readings for cells 
treated with vehicle. 
 
2.4 Data Analysis 
 
2.4.1 ABTS and DPPH data reduction 
 
The following equations illustrate IC50 
determination for the ABTS and DPPH methods;  
 
∆Absorbance = [(ACONTROl - ASAMPLE)          (1)  
                                                                             
% inhibition = [(ACONTROl - ASAMPLE)/ ACONTROL]x 
100%            (2)      
                                               
where ACONTROL is the initial absorbance of the 
ABTS or DPPH working reagent and ASAMPLE is 
the absorbance after incubation with curcumin or 
neem leaf extracts for 30 minutes. The 
concentration of antioxidant that neutralizes 50% 
of ABTS or DPPH radicals (IC50) was determined 
from the relation, IC50= 50/ GRAD, where GRAD 
is the gradient for a graph of % ABTS inhibition 
(Y-axis) plotted versus concentration (x- axis) 
[43]. 
 
2.4.2 Sensitivity, precision, and minimum 
detectable concentrations for 
antioxidants  
 
The assay sensitivity was determined from the 
gradient (GRAD) of calibration graphs where 
absorbance is plotted versus gallic acid or trolox 
concentration. Values for the GRAD (M-1) were 
subjected to pathlength correction to convert to 
the molar absorptivity (ε, M-1 cm-1) as described 
recently; ε = GRAD/ L (cm) where L = pathlength 
for microplate reader [44]. Under the conditions 
of this study L = 0.5 cm (TPC method) or L= 0.8 
cm (FRAP, DPPH, ABTS methods). The error of 
analysis was determined by the average 
coefficient of variation (CV%), where CV%= 
(SD/Mean) x 100%) using values for mean and 
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standard deviation (SD) for measurements. All 
analytical procedures had a measure for within 
and between assay precision. The minimum 
detectable concentration (MDC) is the least 
concentration of antioxidant that is detectable 
above the background noise. MDC was 
determined from [45] the relation, 
 
MDC = 3.0 SD0 / GRAD           (3) 
 
where SD0 is the standard deviation for analysis 
using a reagent “blank” (0 µM) and GRAD is the 
gradient of calibration graph. The upper limit of 
detection (ULD) for antioxidants was determined 
as the highest concentration of reference 
antioxidant, for which r-squared (R2) is close to 
1.0. The concentration range between MDC and 
ULD represents the linear dynamic range for 
assays.  
 
2.4.3 Total antioxidant capacity for neem and 
curcumin samples 
 
The antioxidant capacity of curcumin and neem 
leaf extracts were determined in terms of trolox 
equivalents (TE: mmol/g) and gallic acid 
equivalents (GAE: mmol/g) using the relation,  
 
 
  (4) 
 
where ∆A = absorbance change corrected for the 
reagent blank, Av = total assay volume (300 µl), 
Spv = sip volume (20 µl) of sample analyzed, 
Cext= concentration of curcumin / neem leaf 
extracts (g/l), DF = dilution for extracts prior to 
analysis (DF = 1 for undiluted extract). To 
express antioxidant activity in terms of trolox/ 
gallic acid equivalent antioxidant activity (TE/ 
GAE; mmol/g) then GRAD from the trolox/gallic 
acid calibration graph was inserted into equation 
4.  
 
2.4.4 Statistical analysis 
 
All experiments were repeated on 3 different 
occasions with 12-48 replicates per drug 
concentration. Routine data analysis were 
conducted using MS excel. One-way analysis of 
variance ANOVA tests were performed by 
Microsoft SPSS version 22 (IBM Corporation) 
with Tukey post hoc analysis for the separation 
of means. P < 0.05 was considered to be 
statistically significant. Paired t-tests were 
performed on a calculator at www.graphpad.com. 
 
3. RESULTS  
 
3.1 Antioxidant Activities  
 
Extracts of curcumin prepared using methanol 
and neem prepared using water had a solids 
content of 0.9 (mg/ ml) and 30.2 (mg/ ml). The 
corresponding percentage yield of extraction was 
90% and 30%. Fig. 1 shows four calibration 
graphs for antioxidant assays used in this study, 
with gallic acid reference. All assays had linear 
responses with coefficients of regression (R2) > 
0.96. The data were fitting a straight-line 
equation (Y = x. GRAD) where, Y = absorbance 
and x = concentration of antioxidant, and GRAD 
= slope of the line. Based on the molar 
absorptivity (ε, (M-1 cm-1) value for gallic acid 
(Table 1) the order of assay sensitivity was; 
DPPH > TPC > ABTS > FRAP assay. By 
comparison, the order of sensitivity using trolox 
as reference antioxidant was; ABTS > DPPH > 
TPC > FRAP assay (Table 1). The MDC and 
other assay parameters are reported in Table 1.  
For gallic acid as reference antioxidant the 
within-assay precision (CV%) for the TPC, 
FRAP, DPPH or ABTS assay was 6.0%, 1.3%, 
4.5% or 2.3%, respectively. Using trolox as 
reference, the within-assay CV% for TPC, FRAP, 
DPPH or ABTS assay was, 7.5%, 1.9%, 4.4% or 
1.4% respectively. The between-days CV% for 
the assays is shown in Table 1. 
 
The antioxidant capacity for curcumin and neem 
leaf extract expressed as TE (Fig. 2) or GAE 
(Table 2) varied according to the type of assay 
adopted.  
 
From Table 2, the highest antioxidant                
capacity estimates were observed with the    
FRAP assay for neem. The other assays 
produced an antioxidant capacity of 22-30.4 
(mmol GAE/100 g) for neem powder and                  
16-54 (mmol GAE/100 g) for curcumin. For                  
neem leaf extract, antioxidant capacity 
determined with the TPC and ABTS assay were 
not significantly different (Table 2). Likewise, for 
curcumin, the TPC / FRAP and also ABTS/ 
DPPH were statistically similar. In Table 2, the 
numbers of samples (N‡) varied between the 
four different assays. All measurements involved 
at least 3 replicate experiments and multiple 
dilutions of test samples to reduce the effect of 
sample colour. Data showing no significant 
difference for the results from different dilution 
were averaged. Alternatively, where there was a 
significant difference due to sample dilution then 
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the highest antioxidant capacity (GAE/TE)  
estimates, normally obtained at higher dilutions, 
were used as representative data (Table 2 and 
Fig. 2).  
 
 
 
Fig. 1. Antioxidant capacity assays using gallic acid 
Notes: Gallic acid as standard compound. TPC =Folin-Denis assay, FRAP =Ferric reducing antioxidant potential 
assay, DPPH = 2, 2-diphenyl-1-picrylhydrazyl assay, ABTS = (2, 2′-azino-bis-3-ethylbenzthiazoline-6-sulphonic 
acid assay. For all assays absorbance were read different wave-lengths of 760 nm (TPC), 562 nm (FRAP assay), 
515 nm (DPPH assay) and 734 nm (ABTS assay) 
 
Table 1. Characteristics of four different antioxidant assays used in this study 
 
Assays 
♣ 
Gallic acid Trolox standard 
ε, (M-1 cm-1) R2‡ CV 
(%) 
MDC† 
(µM) 
ε, (M-1 cm-1) R2‡ CV 
(%) 
MDC† 
(µM) Mean SEMΘ Mean SEMΘ 
FRAP 3564 90 0.994 7.8 6.5 450 13 0.995 3.4 50.4 
ABTS 14184 896 0.967 10.8 2.5 12169 205 0.997 7.5 2.8 
TPC 16062 582 0.993 15.9 23.2 4464 206 0.981 8.8 20.8 
DPPH 48409 1609 0.997 6.3 4.8 10325 564 0.974 7.7 16.6 
♣ Abbreviations: TPC assay= Folin-Denis assay, FRAP assay= Ferric reducing antioxidant potential assay, 
DPPH assay= 2, 2-diphenyl-1-picrylhydrazyl assay, ABTS assay = 2,2′-azino-bis-3-ethylbenzthiazoline-6-
sulphonic acid assay;  (Θ) Molar absorptivity (ε) is mean (+/-) standard error (SEM) , (‡) R2 equal to r-squared 
values that range from 0 to 1, while 0 representing no statistical correlation between the data and a line, and 1 
representing completely fit between the data and the line drawn through them, (†) MDC = Minimum Detectable 
Concentration 
 
 
 
Fig. 2. Effect of assay method on antioxidant capacity of neem (Azadirachta indica) extract and 
curcumin expressed as trolox equivalent (TE) 
Assays were, total phenols (TPC-), FRAP (Ferric reducing antioxidant potential), DPPH (2, 2-diphenyl-1-
picrylhydrazyl), and ABTS (2,2′-azino-bis-3-ethylbenzthiazoline-6-sulphonic acid) methods. Bars show means+/- 
SEM, different letters show significant differences (P <0.05) 
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Table 2. Antioxidant capacity of neem (Azadirachta indica) and curcumin as Gallic Acid 
Equivalents (GAE) 
 
Assay method ♣ N‡ Neem leaf powder 
(GAE, mmol/100 g) 
Curcumin 
(GAE, mmol/100 g) 
Mean SEMΘ Mean SEMΘ 
TPC 96 27.1 a 2.0 51.4 b 2.0 
FRAP 46 540.8 c 7.0 54.2 b 4.0 
DPPH 40 30.4 b 0.0 16.0 a 0.0 
ABTS 87 22.0 a 1.0 23.4 a 1.0 
♣ Abbreviations: TPC assay = Folin-Denis assay, FRAP assay = Ferric reducing antioxidant potential assay, 
DPPH assay= 2, 2-diphenyl-1-picrylhydrazyl assay, ABTS assay = 2,2′-azino-bis-3-ethylbenzthiazoline-6-
sulphonic acid assay, GAE = Gallic acid equivalent antioxidant capacity, TE = Trolox equivalent antioxidant, 
capacity, (Θ)SEM = standard error of mean, (‡)N = number of samples. (a-e) Columns with different letters are 
significantly different (p <0.05) 
 
In other studies, we found the concentration of 
curcumin and neem leaf extract necessary for 
50% inhibition (IC50) of ABTS was 7.5 (µg/ ml) 
and 1.7 (µg/ ml) respectively. By comparison, the 
IC50 values for inhibition of DPPH radicals was 
7.8 (µg/ ml) and 3.8 (µg/ ml) for curcumin and 
neem leaf extracts, respectively. Based on the 
values for IC50, neem leaf extract showed ~4-
times greater ABTS inhibition or 2-times greater 
DPPH inhibition compared to the equivalent 
concentration (µg/ml) of curcumin. The IC50 
values are given as the actual concentrations in 
the reaction system. 
 
3.2 Cell Viability 
 
In Fig. 3, treatment of MCF-7 cells with ALA (0-
500 µM) or neem leaf extract (0-88 µM, GAE) 
produced a concentration-dependent decrease of 
cell viability. The final panel in Fig. 3 shows that 
the losses of cell viability were less severe if cells 
were treated with a combination of neem plus 
ALA as compared to each of these agents 
individually.  
 
Fig. 4 shows MCF-7 cell treatments with 
curcumin (0-50 µM), ALA (0-500 µM), or their 
combinations. The concentrations of the 
individual agents required to inhibit MCF-7 cells 
by 50% (IC50) were estimated (from Figs. 3 and 
4) as 50 µM for ALA whilst IC50 = 17.8 µM GAE 
for neem extract and IC50 = 7.2 µM for curcumin. 
There were significantly lower decreases of cell 
viability for combination treatments, whilst the 
individual treatments using ALA, or curcumin 
produced higher inhibitions of MCF-7 cells. 
 
 
 
Fig. 3. Effect of neem, α-Linolenic acid or their combination on MCF-7 cell viability 
MCF-7 cells were treated with neem leaf extract (0-88 µM), ALA (0-500 µM), or combinations for 72 hr. Bars 
show means +/- SEM. Different letters indicate significant differences (P < 0.05) 
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Fig. 4. Effect of curcumin, α-Linolenic acid or their combination on MCF-7 cell viability 
MCF-7 cells were treated with curcumin ALA or combinations for 72 hr. Bars show means +/- SEM. Different 
letters indicate significant differences (P < 0.05) 
 
4. DISCUSSION 
 
4.1 Extraction Yield and Antioxidant 
Activity  
 
Under the conditions of this study, curcumin was 
insoluble in water and 90% soluble in methanol. 
The weight-yield for neem extraction with water 
(30%) compares with previous reports of 58%, 
19%, 17% and 4% with water, butanol, ethyl 
acetate, or hexane solvent [25,26]. The high yield 
obtained in polar solvent was probably due to 
high solubility of major components of neem in 
high polarity solvent. Methanol is expected to 
extract more nonpolar components compared to 
water.  
 
In the assays described here, multiple dilutions 
were adopted a precautionary measure for 
colorimetric analysis, to ensure sample 
absorbances occur within the linear range of the 
assay. Secondly, dilutions were adopted to 
address a more stealthy issue which is the 
inadvertent precipitate formation when a 
concentrated extract is added to an assay 
system. Where a system behaves ideally, then 
dilutions should have no effect on final TAC 
results. 
 
Estimates for TAC (Fig. 1, Table 2) differ 
according to different assays which are expected 
since different assays employ different 
chemistries, and solvent conditions [39,46]. For 
such reasons, multiple methods are 
recommended for TAC assessment [46]. The 
performances of different assays may be difficult 
to compare quantitatively also because each 
laboratory has developed its own standard 
operating procedures for analysis whereas a 
wide variety of conditions affect assay results, 
e.g. assay time, sample volume, wave-length, 
and the type of reference antioxidants used. We 
found the antioxidant activity for trolox was 
unaffected at pH 4.0-pH 10.0 whereas gallic acid 
showed rising antioxidant activity with increasing 
pH so the former maybe preferable as a standard 
[47]. The Folin assay, formerly used to determine 
TPC in food products, is a suitable general assay 
for antioxidants [41]. Both the ABTS and DPPH 
assays are widely used also due to their high 
sensitivity, short analysis times and high 
reproducibility. Studies using ABTS and DPPH 
assay typically adopt trolox as reference 
antioxidant [39,40]. Here, all 4-assays were 
calibrated with gallic acid and trolox as reference 
compounds to allow a comparison of results.   
 
The antioxidant methods could be ranked 
according to molar absorptivity values (Table 1), 
but the ranking differed when trolox or gallic was 
used as references. A further ranking was 
possible based on values for the MDC which 
takes account of the precision for different 
methods (eq. 3). Data from Table 1 is should not 
pit one assay method against another because 
different assays emphasise different antioxidant 
characteristics [46]. 
 
The antioxidant capacity of neem leaf extract 
was reported previously [23-27] but no previous 
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study employed all the four assays used in the 
current paper. The free radical quenching 
capacity for neem leaf water extract for DPPH 
and ABTS radicals produced IC50 estimates of 
26.5 µg/ml and 96 mmol/100 g [23] which are 3-4 
fold higher than values reported in the current 
study. We found also that IC50 values were 2-fold 
lower for ABTS as compared to the DPPH assay 
(Table 2), which suggests that former may be 
more sensitive towards water extractable 
antioxidants from neem leaf. Ghimire et al. [26] 
reported the total phenols content for neem leaf 
water extract as 66.37 (mg GAE/g) equivalent to 
39 (mmol GAE/100g) or 6.6% w/w. By contrast, 
the total phenols content for neem leaf extracts 
was, 38% (w/w), 20% (w/w) or 15% (w/w) using 
ethanol, ethyl acetate or methanol as solvent, 
respectively [24]. Others reported a total phenols 
content ranging from 9.6% - 11.5% w/w for 
water, methanol and ethyl acetate neem leaf 
extracts [25]. The total phenols value from the 
current study was 4.5% (w/w) or 27 (mmol 
GAE/100 g) which is in fair agreement with 
reported literature values. Moreover, extraction 
using nonpolar solvents is expected to increase 
the recovery of Total Phenols and polyphenols 
[25,26]. 
 
Using curcumin dissolved in ethanol the IC50 was 
34.86 µg/ ml from the DPPH assay or 18.97 µg/ 
ml for the ABTS assay [19] as compared with 
values of 7.8 µg/ ml and 7.5 µg/ ml (this study) 
with methanol solvent, respectively. Interestingly 
the antioxidant capacities noted in Fig. 2 and 
Table 2 for neem and curcumin are comparable 
to values reported for other herbals and 
traditional medicines; a survey of 3500 natural 
agents found that herbals and traditional 
medicines had the highest antioxidant capacity 
ranging from 230-1448 mmol/100 g on a TE 
basis [10]. 
 
4.2 Cell Viability 
 
Omega-3 fatty acids inhibit the proliferation of 
MCF-7 (ER+) cells and the order of effectiveness 
was EPA = DHA > ALA [3,4]. Nevertheless ALA 
is considered unique in terms of the ability to 
substantiate anticancer effects based on 
population studies [4]. A 24 hr. treatment with                
75 µM of ALA produced 55% inhibition of MCF-7 
cells [4]. However, treatment with 50 µM ALA for 
5-days reduced MCF-7 proliferation by 33% [48] 
and a seven day treatment with 30 µM ALA 
reduced cell growth by 30% [3]. In the current 
study, the 50% inhibitory concentration for ALA 
(IC50) was 50 µM with 72 hrs treatment (Fig. 3). 
The IC50 for curcumin inhibition of MCF-7 was 
reported previously as, 31.1 µM, 21.3 µM or 11.3 
µM for cells treated for 24, 48 or 72 hrs [32,34]. 
Another literature IC50 value for curcumin using 
MCF-7 was 60 µM following 48 hr treatment [35]. 
These results compare with our curcumin IC50 of 
7.2 µM for 72 hr exposure. There is only one 
relevant literature study of ethanoic neem leaf 
extract (ENLE) on MCF-7 cells [36] which found 
that cell viability was reduced by ~50% with 400 
g/ml extract (2.4 µM GAE). By comparison, our 
study found IC50 was 17.8 µM (GAE) using a 
water neem extracts.  
 
To summarize, the present paper confirms that 
ALA, neem and curcumin are all inhibitory for 
MCF-7 cells individually. IC50 estimates for the 
individual components were similar to values 
from past studies for ALA [3,4], curcumin 
[32,34,35] or neem [36]. However, this appears 
to be the first published report to compare neem, 
curcumin and ALA anticancer properties within a 
single study. The results indicate that curcumin, 
neem leaf extract and ALA inhibit MCF-7 cell 
proliferation in a concentration-dependent 
manner and that the order of effectiveness was 
tentatively, curcumin > neem leaf water extract > 
ALA.  
 
Synergistic interactions between DHA and 
curcumin were examined recently [49] but no 
combination studies involving ALA, neem or 
curcumin appear to be available. In-vitro studies 
and research using rodent models showed that 
n-3 fatty acids inhibit breast cancer cells via 
multiple pathways including, the modification of 
membrane composition, inhibition of 
cyclooxygenases or activation of PPAR [5-8]. 
The findings of the current combination study 
supports the hypothesis that lipid peroxidation 
may be implicated anticancer effect of ALA [5-8]. 
Combination treatments using ALA and curcumin 
or neem on MCF-7 cells found no improvements 
compared to individual treatments.  
 
5. CONCLUSION 
 
This study confirms that curcumin and neem are 
substantive antioxidant materials comparable to 
other herbal and traditional medicinal agents 
[10]. In-vitro test using MCF-7 cells indicated that 
ALA, curcumin and neem leaf extract produce a 
concentration-dependent inhibition of cancer cell 
growth. Combination treatments using ALA and 
curcumin or ALA and neem extract, resulted in a 
significant loss in efficacy of each agent. The 
findings are consistent with past literature 
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suggesting that lipid peroxidation and oxidative 
stress may be negative risk factors for breast 
cancer and that antioxidants may on some 
occasions impair rather than support other 
therapies [28-30]. It is not possible to eliminate 
other possible underlying causes for the 
observed findings. There are further limitations to 
this study. The design of this study did not 
extend to a formal analysis of interactions using 
isobolograms. The study was also an in-vitro 
study with all the usual well-known limitations. 
Though in-vitro findings may provide a rational 
for other studies, the interpretations of data 
should not be extrapolated to more complex 
systems such as animal models or human 
studies. The results obtained with MCF-7 cells 
should be examined with other cells lines 
including MCF-10A epithelial cells. Interestingly, 
a recent study showed that a combination of 
curcumin and ALA increased the synthesis of n-3 
fatty acids in the brain [50]. More extensive 
studies will be needed to improve current 
understanding of the effect of antioxidants on 
ALA anticancer activity.  
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